Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
3(42.9%)
Phase 3
2(28.6%)
Phase 2
2(28.6%)
7Total
Phase 1(3)
Phase 3(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT06622239Phase 2Not Yet Recruiting

Trial to Evaluate the Effects of Naltrexone in Nonsuicidal Self-injury

Role: collaborator

NCT06154434Phase 1Completed

Bioequivalence Study in Healthy Subjects by Using of Chlorpromazine HCl 100mg Tablets

Role: lead

NCT04849026Phase 1Completed

Bioequivalence Study in Patients With Schizophrenia by Using Clozaril 100 mg Tablet (Clozapine) and WID-CLZ18

Role: lead

NCT05168007Phase 3Unknown

Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With Schizophrenia

Role: lead

NCT04095182Phase 1Completed

Clinical Trial for Zebinix (Eslicarbazepine Acetate) in Healthy Korean and Caucasian Adult

Role: lead

NCT01820481Phase 2Completed

Safety and Efficacy of WIN-901X in Asthma

Role: lead

NCT01245530Phase 3Completed

An Efficacy and Safety Study of INM-176 for the Treatment of Patients With Alzheimer Type Dementia

Role: lead

All 7 trials loaded